Biotech sector steadily growing with over 1,100 startups in the last year: K. VijayRaghavan

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

K. Vijay Raghavan, former director of National Centre for Biological Sciences, in conversation with Jacob Koshy, Science Editor, The Hindu at the Biotech Conclave 2026 in Chennai on Friday. | Photo Credit: B. Velankanni Raj

Quality of education, regulatory frameworks governing the biotechnology sector, economic factors, global competition and the potential of AI to democratise spaces were some of the many topics discussed in a wide-ranging conversation at the Biotech Conclave 2026 , presented by VIT Chennai in association with The Hindu , on Friday (September 11, 2026).

Former principal scientific advisor to the Union government K. VijayRaghavan, who has worked with the National Centre for Biological Sciences and the Tata Institute of Fundamental Research, in conversation with Jacob Koshy, Science Editor, The Hindu , highlighted the importance of fundamental research — despite potential arguments that it was openly available from all over world — still being essential to invest in as today’s technologies could not simply be imported without understanding, and that the development of science and curiosity in our context was crucial.

On the regulatory frameworks in India, he noted that a lot of regulatory principles, till recently, were drawn from the West and there was an assumption that the more regulations there were, the better it was. But this resulted in only companies with deep pockets being able to jump through hoops, while a lot of innovation got thrown out. A deep understanding, he said, was needed for contextual regulation.

The Hindu–VIT Conclave explores advances in biotechnology and healthcare

The Hindu-VIT Biotech Conclave in Chennai discusses new frontiers in science

Experts call for stronger industry-academia partnerships to make India a global biopharma hub

Focus on translational research, VIT pro-vice-chancellor T. Thyagarajan urges students

Biotech students must step out of comfort zones, embrace multiple roles: Suchitra Ella

On the new innovations and startup space in biotechnology, Prof. VijayRaghavan said that the sector was growing at a compound annual growth rate (CAGR) of 12-13% or more, with over 1,100 startups started in the last year. But the challenge for small players today is that this is an extremely competitive space, he said. Even the stable, bigger companies are under threat, he said, because of the advent of new science, robotics and AI. This is a warning call for Indian biotechnology companies, he said, to invest in a fundamental connect between academia, global academia and translation.

While AI was a democratising factor in some ways in terms of allowing experiments that could once only be conducted in the lab to be conducted on tabletops now and offered great potential, this also presented regulatory challenges and threats, he noted.

Prof. VijayRaghavan also stressed that the issue of quality education at scale in India needed to be urgently addressed.